Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

exchanges : Amex    crawled time : 12:30    save search

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
CRMD | $5.42 -0.37% -0.37% 630K twitter stocktwits trandingview |
Health Technology
| | O: 1.61% H: 2.74% C: 0.42%

commercial agreement
TASEKO ANNOUNCES OFFERING OF US$500 MILLION OF SENIOR SECURED NOTES DUE 2030
Published: 2024-04-08 (Crawled : 12:30) - prnewswire.com
TGB | $2.53 3.26% 0.75% 2.8M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 4.33% H: 2.07% C: 1.66%

million offering
Matinas BioPharma Prices $10 Million Registered Direct Offering
Published: 2024-04-03 (Crawled : 12:30) - globenewswire.com
MTNB | $0.19 -1.04% 0.0% 960K twitter stocktwits trandingview |
Health Technology
| | O: -20.29% H: 0.0% C: -18.46%

million direct offering biopharma
Odysight.ai Announces 2023 Financial Results and Provides Corporate Update
Published: 2024-03-27 (Crawled : 12:30) - globenewswire.com
NHC | $87.95 0.31% 0.0% 51K twitter stocktwits trandingview |
Health Services
| | O: 0.11% H: 1.89% C: 1.79%

update financial results
Taseko Acquires 100% of Gibraltar Mine
Published: 2024-03-25 (Crawled : 12:30) - prnewswire.com
TGB | $2.53 3.26% 0.75% 2.8M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -3.52% H: 11.46% C: 11.46%


Servotronics Announces Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-03-22 (Crawled : 12:30) - prnewswire.com
SVT | $11.95 2.49% -1.67% 1.1K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 4.56% H: 7.32% C: -1.59%

financial results
Inuvo Launches Enhanced IntentKey Insights Dashboard
Published: 2024-03-19 (Crawled : 12:30) - globenewswire.com
INUV A | $0.329 0.31% -1.67% 100K twitter stocktwits trandingview |
Technology Services
| | O: -1.18% H: 2.24% C: -5.46%


White Gold Corp. Announces Upcoming Conferences
Published: 2024-03-12 (Crawled : 12:30) - globenewswire.com
NEM | $38.55 -0.03% 0.0% 6.4M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -2.13% H: 0.03% C: -1.77%
KGC | $6.51 1.4% 0.14% 16M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -2.33% H: 0.73% C: 0.55%
AEM | $63.47 1.57% 0.39% 3.6M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -1.82% H: 1.45% C: 1.28%
WRN 2 d | $1.405 0.36% 1.92% 59K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -0.75% H: 3.76% C: 2.26%


Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
CANF | $2.02 3.06% -2.48% 10K twitter stocktwits trandingview |
Health Technology
| | O: -0.45% H: 2.27% C: 2.27%

europe liver conference distribution pancreatic treatment namodenoson
SilverCrest Announces Updated Annual Audited Financial Statement Filing Date and Conference Call
Published: 2024-03-07 (Crawled : 12:30) - prnewswire.com
SILV | $7.57 6.02% 0.0% 2.3M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 0.36% H: 0.0% C: -1.06%

conference financial
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Published: 2024-03-06 (Crawled : 12:30) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K twitter stocktwits trandingview |
Consumer Non-Durables
| | O: 1.5% H: 1.23% C: 1.05%
PPRUY | News | $36.03 -0.11% 330K twitter stocktwits trandingview |
Manufacturing
| | O: 0.81% H: 0.22% C: -0.18%
PHGE | News | $0.2937 4.86% 0.1% 110K twitter stocktwits trandingview |
Health Technology
| | O: 211.55% H: 18.75% C: -4.46%

million therapeutics agreement
NexGen Energy to Host Year End Conference Call
Published: 2024-03-06 (Crawled : 12:30) - prnewswire.com
NXE | $7.64 -0.39% 0.0% 4M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 0.66% H: 2.49% C: 0.13%

conference energy year
Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
Published: 2024-02-28 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K twitter stocktwits trandingview |
Health Technology
| | O: -44.58% H: 25.45% C: 11.36%

pl9643 disease eye trial results
Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada
Published: 2024-02-28 (Crawled : 12:30) - biospace.com/
CANF | $2.02 3.06% -2.48% 10K twitter stocktwits trandingview |
Health Technology
| | O: -1.9% H: 4.37% C: 0.98%

patent canada
Actinium Announces Iomab-B Markedly Increases Long Term Survival in Patients 65 Years or Older with Active Relapsed or Refractory AML in the Phase 3 SIERRA Trial at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®
Published: 2024-02-26 (Crawled : 12:30) - prnewswire.com
ATNM | $6.67 -8.0% 1.2% 420K twitter stocktwits trandingview |
Health Technology
| | O: 2.04% H: 19.98% C: 18.71%

astct active aml trial therapy
Actinium Highlights Improved Survival with Iomab-B in TP53 Positive Relapsed Refractory Acute Myeloid Leukemia Patients in the SIERRA Trial and Other Presentations at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®
Published: 2024-02-23 (Crawled : 12:30) - prnewswire.com
ATNM | $6.67 -8.0% 1.2% 420K twitter stocktwits trandingview |
Health Technology
| | O: 4.45% H: 1.85% C: -2.56%

tp53 astct positive leukemia trial therapy
Highland Copper Announces Appointment of Barry O’Shea as Chief Executive Officer
Published: 2024-02-22 (Crawled : 12:30) - globenewswire.com
NGD | $1.73 1.16% 7.4M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -0.86% H: 0.0% C: -4.35%


Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
MTNB | $0.19 -1.04% 0.0% 960K twitter stocktwits trandingview |
Health Technology
| | O: 4.35% H: 11.21% C: -0.46%

mat2203 fda treatment biopharma trial agreement
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Published: 2024-02-15 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K twitter stocktwits trandingview |
Health Technology
| | O: -2.66% H: 0.25% C: -21.84%

year update financial results
Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
Published: 2024-02-09 (Crawled : 12:30) - prnewswire.com
PTN | $1.89 -0.53% 0.0% 180K twitter stocktwits trandingview |
Health Technology
| | O: 1.24% H: 4.42% C: 4.42%

report year
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.